IMCDX vs. MEDIX

Last updated Jun 4, 2026

IMCDX (Voya Emerging Markets Corporate Debt Fund) and MEDIX (MFS Emerging Markets Debt Fund) are both Emerging Markets Bonds funds. A 0.71 correlation means they provide meaningful diversification when combined. IMCDX charges 0.10%/yr vs 0.81%/yr for MEDIX.

Performance

IMCDX vs. MEDIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Voya Emerging Markets Corporate Debt Fund (IMCDX) and MFS Emerging Markets Debt Fund (MEDIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

IMCDX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

MEDIX

• 1D: 0.16%
• 1M: 1.09%
• YTD: 2.46%
• 6M: 3.09%
• 1Y: 12.40%
• 3Y*: 9.48%
• 5Y*: 2.13%
• 10Y*: 3.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

IMCDX vs. MEDIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
IMCDX Voya Emerging Markets Corporate Debt Fund	0.00%	0.00%	6.44%	8.51%	-13.79%	0.08%	8.35%	13.65%	-1.77%	9.40%
MEDIX MFS Emerging Markets Debt Fund	2.46%	12.48%	5.92%	9.42%	-15.97%	-2.40%	8.01%	14.12%	-4.99%	9.64%

Correlation

The correlation between IMCDX and MEDIX is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.58
Correlation (5Y) Calculated over the trailing 5-year period	0.69
Correlation (10Y) Calculated over the trailing 10-year period	0.72
Correlation (All Time) Calculated using the full available price history since Aug 1, 2012	0.71

The correlation between IMCDX and MEDIX shifts across timeframes, from 0.58 (3 years) to 0.72 (10 years), reflecting how their relationship changes across market environments.

Return for Risk

IMCDX vs. MEDIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDIX

MEDIX Risk / Return Rank: 84
MEDIX Sharpe Ratio Rank: 94
MEDIX Sortino Ratio Rank: 96
MEDIX Omega Ratio Rank: 93
MEDIX Calmar Ratio Rank: 65
MEDIX Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMCDX vs. MEDIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Voya Emerging Markets Corporate Debt Fund (IMCDX) and MFS Emerging Markets Debt Fund (MEDIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	IMCDX	MEDIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	3.25	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.36	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.64	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.98	—

Drawdowns

Drawdown Indicators

	IMCDX	MEDIX	Difference
Max Drawdown Largest peak-to-trough decline	—	-35.31%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-4.12%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-7.48%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-27.40%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-27.40%	—
Current Drawdown Current decline from peak	—	0.00%	—
Average Drawdown Average peak-to-trough decline	—	-4.44%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.94%	—

Volatility

Volatility by Period

	IMCDX	MEDIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	1.39%	—
Volatility (6M) Calculated over the trailing 6-month period	—	3.22%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	3.92%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	5.89%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	5.87%	—

IMCDX vs. MEDIX - Expense Ratio Comparison

IMCDX has a 0.10% expense ratio, which is lower than MEDIX's 0.81% expense ratio.

Dividends

IMCDX vs. MEDIX - Dividend Comparison

IMCDX has not paid dividends to shareholders, while MEDIX's dividend yield for the trailing twelve months is around 5.04%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IMCDX Voya Emerging Markets Corporate Debt Fund	0.00%	0.00%	4.08%	4.21%	3.80%	6.14%	4.64%	4.99%	5.30%	4.79%	5.22%	5.11%
MEDIX MFS Emerging Markets Debt Fund	5.04%	5.22%	5.68%	4.90%	5.51%	4.33%	4.07%	4.59%	4.87%	4.46%	4.86%	5.25%

Frequently Asked Questions

Can I hold both IMCDX and MEDIX in my portfolio?

IMCDX and MEDIX have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.